November 8, 2009: Know The Nanotechnology Movement.
PC Laptop Shop
October 15, 2009: UM MNIMBS and
NanoBio get $9.4M new grant injection for adjuvant work. See John Carrol's article in Fierce Vaccines
October 15, 2009: NanoBio reports good results on cystic fibrosis studies. By Tom Henderson Crain's Detroit Business
October 15, 2009: Research and Markets: Dendrimer-Based Nanomedicine: Essential Book for Those Involved in Nanotechnology, Macromolecular Science, Cancer Therapy or Drug Delivery Research Earth Times
September 28, 2009:
Nanotech battlefield treatment to ease pain and limit dangerous side effects By Jeff Salton Gizmag
September 15, 2009:
Introducing Nanoemulsion Lotion for Treatment of Severe Burns.
R & D Magazine
September 14, 2009:
Nanotechnology treatment for burns reduces infection, inflammation
Nanotechnology treatment for burns reduces infection, inflammation. InSciences Organisation
August 17, 2009:
NanoBio to Present Preclinical Data on its Novel, Nanoemulsion-based Vaccine Adjuvant Platform at the Immunotherapeutics & Vaccine Summit. PharmaLive
This is an example of successful translation of research. The
intranasal nanoemulsion-adjuvanted influenza vaccine that NanoBio Corp. now has in Phase I studies was originally developed at MNIMBS.
August 16, 2009: UM researcher aims to treat CF through nanoemulsion tech. By Ryan Beene Crain's Detroit Business
February 9, 2009: 8:30am, Chis V. Kelly will do his Final Oral Examination for his thesis: "The Biophysics of nanoparticles interacting with the plasma membrane."
Location: BSRB 1130-C.
Chair: Professor Brad Orr
January 19, 2009: Other Voices: U-M can take the lead in combating disease with technology
by John Prensner, Maggie Kober and Adam Castano in Mlive.com Maggie Kober is now a 2nd year medical student at UofM and is a former undergrad in MNiMBS for 3.5 years.
January 5, 2009: Mark Banaszak Holl, professor of chemistry and of macromolecular science and engineering at the University of Michigan, was elected as a fellow of American Association for the Advancement of Science (AAAS).
"Banaszak Holl studies the development of polymer-based drug transport agents and their interactions with lipid bilayers, organelles and cells. He was honored by AAAS for distinguished contributions bridging disciplinary boundaries in studies of chemical and biochemical processes at the nanoscale." The University Record.
Tuesday, December 2, 2008; 2:30 PM, Paul Edward Makidon will do his Final Oral Examination for his thesis
OIL-IN-WATER NANOEMULSIONS AS MUCOSAL VACCINE ADJUVANTS:
CHARACTERIZATION, MECHANISM, FORMULATION, AND DEVELOPMENT OF A
NANOEMULSION-BASED BURKHOLDRERIA CENOCEPACIA VACCINE
Location: 1170A and 1150B BSRB
Chair: Professor James R. Baker, Jr.
August 13, 2008
Nano vaccine for hepatitis B produces strong immunity
April 21 , 2008 - Dr. James R. Baker Jr. has been named the Distinguished University Innovator for 2008. |
